# Hipgnosis Songs Fund suspends dividend for remainder of the year

- Link: https://www.directorstalkinterviews.com/hipgnosis-songs-fund-suspends-dividend-for-remainder-of-the-year/4121136867
- Published: 2023-12-21T07:16:39+00:00
- Author: Amilia Stone

**Hipgnosis Songs Fund Limited** (LON:SONG), which offers investors a pure-play 
exposure to songs and associated intellectual property rights, and its Investment
Adviser, has announced the Company’s interim results for the six-months to 30 September
2023.

**Financial Headlines**

·      Operative NAV per share decreased 9.2% to $1.7392 (31 March 2023: $1.9153),
driven primarily by a reduction in the Fair Value of the Portfolio

o  As at 30 September 2023, Operative NAV per share in Sterling 142.49p (£:$ exchange
rate 1.22055);

o  As at 19 December 2023, Operative NAV per share presented in Sterling 136.53p
per Share (£:$ exchange rate 1.274).

·      Gross revenue from continuing operations for the period $63.2 million (H1
2022-3: $86.4 million)

·      Net revenue from continuing operations fell to $54.0 million (H1 2022-3: 
$76.8 million) primarily driven by $11.9 million reversal of CRB III accrual due
to lower anticipated future retroactive payments

·      Underlying net revenue (excluding CRB III accruals) up 14.0% to $65.8 million(
H1 2022-23: $57.6 million)

·      Pro-forma Annual Revenue (PFAR), which shows the gross royalty statements
received or receivable within the reporting period and does not include any revenue
accruals under IFRS grew 10.4% to $64.9 million (Six months to 30 Sept 2022: $58.8
million)

·      Total dividends of 2.6250p per ordinary share paid

o  October 2023 dividend withdrawn

o  Dividends suspended for at least remainder of financial year

·      Total debt of $674.0 million as at 31 September 2023 (31 March 2023: $648.2
million) representing 32.0% of Operative NAV (31 March 2022: 28.0%)

**Operational Headlines**

·      Strategic Review, led by the Board, underway following rejection of the Continuation
Resolution at the Company’s AGM

o  Shot Tower Capital, LLC as lead adviser to conduct due diligence on the Company’s
assets

o  Investment Adviser invited to propose alternative terms for their future investment
advisory arrangements for the Company

·      Robert Naylor appointed non-executive director and Chair of Company’s Board
following period end; Francis Keeling and Christopher Mills appointed non-executive
directors

·      Sale of c.20,000 non-Core songs representing approximately 1% by value of
the Company’s investment portfolio sold for $23.1 million, a 14.2% discount to the
Portfolio Independent Valuer’s valuation

·      KPMG appointed Company’s auditors

> **Robert Naylor, Chairman, said:**
> “I am delighted to be appointed to the Board, with strong backing from shareholders.
> The Board are clear we are acting in their best interests.
> “I am pleased with the progress made on the ongoing strategic review. The Board,
> through its advisers, has begun due diligence on the Company’s assets with Shot
> Tower LLC, a specialist music rights practice, acting as lead adviser. This process
> will help the new Board bring forward proposals for delivering value to shareholders.
> “Notwithstanding this progress, since I joined the Board there has been a regular
> occurrence of issues raised as a result of ongoing failures in the financial reporting
> and control process. Whilst we consider substantial progress has been made in 
> identifying and rectifying these issues, we have had to suspend the dividend for
> at least the remainder of the year in order to ensure compliance with our banking
> covenants.
> “The newly constructed Board are aware of multiple valuation data points. The 
> Board, made up entirely of non-executive directors, has sought advice from the
> Investment Adviser, as the Company’s delegated executive function, for their opinion
> as to the fair value of the Company’s assets.
> “Regrettably, the Investment Adviser initially refused to provide an opinion. 
> While the Investment Adviser did eventually provide an opinion to the Board, it
> was heavily caveated. Whilst the Board sought for correspondence with the Investment
> Adviser on the matter to be published on the Company’s website in order to provide
> transparency for shareholders, the Investment Adviser has refused to consent under
> the confidentiality clauses of the Investment Advisory Agreement.
> “We note the announcement from Hipgnosis Song Management stating that they will‘
> continue to work in a constructive manner to support the interests of the Company
> and its shareholders’. On behalf of the Board, I therefore urge the Investment
> Adviser to provide the Board with their opinion as to the fair value of the Company
> assets, without caveats, such that we can provide greater certainty and transparency
> to our shareholders.”

**Results call**

Dan Pounder, CFO of Hipgnosis Song Management, will be hosting a call for analysts
and investors at 0830 BST on 4 January 2023.

To register to participate, please contact ir@hipgnosissongs.com.

A recording of the call will subsequently be placed on the Company’s website www.
hipgnosissongs.com/song-investors/

Share on:
